Otsuka Pharmaceutical Companies Europe’s Post

July's pharmaceutical market overview reports for Sweden, Norway and Finland are out! The overview includes monthly market growth rates, top health companies by sales, and detailed sales data for top products. The Swedish market grew by 13%, with B-Myers Squibb and Janssen-Cilag leading. The Norwegian market saw a 20.8% growth, with Novo Nordisk and Pfizer at the top. The Finnish market grew by 16%, led by Orion Pharma and Novo Nordisk.  If you want to have more detailed information about the markets and how to utilize the information, reach out to Björn Ståhl from #IQVIANordics #pharmaceuticalmarket

What did the last pharmaceutical market overview for Finland, Sweden, and Norway look like for the year 2023? IQVIA’s market data for December shows among other things that the top health company in Finland was Orion Pharma with sales of 27M EUR for the month and 292M EUR for the year. The top product was Eliquis by Brist-Myers Squibb. In the Swedish market, the monthly market growth was 6.3%. The top health company was Janssen-Cilag with sales of 267M SEK for the month and 3.217M SEK for the year. The Norwegian market showed high monthly growth with more than 17% partly driven by the top selling product Wegovy FlexTouch by Novo Nordisk with sales of 108M NOK for the month and 691M NOK for the year. #iqvia #iqvianordics

Growth has come from ex-Japan markets

We have reached the final panel of the day at #PharmaCX with Brandi Ascione from Underscore Marketing leading a Field Force + CX discussion featuring Sarmad Salim (Otsuka Pharmaceutical Companies (U.S.)), Christine Pillard, M.S. (Endo Pharmaceuticals), Sohni Dailey (Bristol Myers Squibb) and Chris Tuleya (Underscore Marketing)! Topics of discussion: • What is the role of the field force in customer experience? • How can pharma best leverage the field force to improve the HCP experience, and also the patient experience? • What are some things you should not do with the field force? • What are some specific examples of field force initiatives that have improved overall CX?

💊 Sanofi’s Strategic Move: Acquiring Full Ownership of Doliprane 🏥 On October 3rd, 2024, pharmaceutical giant Sanofi made headlines with its acquisition of full ownership of Doliprane, one of the most recognized over-the-counter pain relief brands in France. This strategic move is set to solidify Sanofi’s position in the self-care and consumer healthcare market. Doliprane, synonymous with paracetamol, has been a cornerstone product for decades. By taking full control, Sanofi aims to bolster its portfolio in pain management and strengthen its grip on a highly competitive market. With the rise of self-medication and growing consumer demand for trusted over-the-counter solutions, this acquisition aligns with Sanofi’s broader strategy to invest in key consumer health products and maintain its leadership in the pharmaceutical industry. 📈 This deal reflects the growing trend of large pharmaceutical companies focusing on consumer health as a core pillar of their growth strategies. It will be interesting to see how Sanofi leverages this new asset moving forward! #Sanofi #Healthcare #Acquisition #Pharmaceuticals #ConsumerHealth #Doliprane #GrowthStrategy #Finance #Breakingnews #Financialpharmaceuticals

📣 Pharma professionals, it’s time to dive into the Baltic market. Ready to compare your sales data across the Nordics and the Baltics? Want to discover new ways to grow your business? We have got some exciting news for you! We have partnered with Softdent , a top provider of pharmaceutical sales data for the Baltics. Now we can offer you data for Estonia, Latvia, and Lithuania, along with our existing Nordic data. Why should you be excited? This partnership allows us to offer you a more comprehensive and valuable service. You can access and compare data across countries and regions. You’ll also gain fresh insights and new perspectives on your markets and competitors. Need Baltic or Nordic data? Here’s how we can help you get it: https://lnkd.in/dK-bRw9Q

June’s pharmaceutical market overview reports for Sweden, Norway and Finland are out! The overview includes monthly market growth rates, top health companies by sales, and detailed sales data for top products. The Finnish market saw a decline of 4.3%, with Orion Pharma leading in sales. The Norwegian market grew by 4.8%, with Novo Nordisk at the top. The Swedish market experienced a slight decline of 1.2%, with Janssen-Cilag leading. #IQVIANordics #pharmaceuticalmarket

"Every decision we make is exceptionally important, which makes my role very interesting". We sat with Sivan Ranon, who manages global supply chain for the Teva Active Pharmaceutical Ingredients (API) organization and end-to-end planning for two of Teva's specialty medicines. Sivan discusses her responsibilities, her excitement about what we make, and some of her most memorable Teva moments. See what makes her successful, which challenges and opportunities she sees in the current global supply chain field, and how are we ensuring our 200 million patients have access to medicine every day, everywhere. https://lnkd.in/dkR5ZydQ #Tevapharm #SupplyChain #MeetOurPeople #TevaAPI

Colonel Eli Lilly, a pharmaceutical chemist and Union Army veteran, founded @EliLilly, serving as president until his passing in 1898. The company grew significantly before and after WWI, expanding its Indianapolis facility. In 1923, it introduced Iletin, the world's first commercially available insulin. Going public in 1952, Eli Lilly later acquired and successfully sold cosmetic giant Elizabeth Arden. Fast forward to today, where Lilly's tirzepatide products have surged, driving the stock up by nearly 100%. Annual revenue soared to over $34.1 billion in 2023, a remarkable 20% increase. With Zepbound approved for obesity, Lilly competes with Novo Nordisk in a duopoly, propelling its market cap to over $800 billion. Wall Street projects GLP-1 sales alone to bring in $13 billion this year, positioning Lilly to become the first trillion-dollar healthcare company. Witness Eli Lilly's remarkable journey from its roots to becoming the largest healthcare company globally. Stay tuned for more insights on how Lilly is reshaping the healthcare landscape. #EliLilly #Pharmaceuticals #Healthcare #BusinessHistory #StockMarket #Innovation

Finding and working successfully with rare disease key opinion leaders is a must-do but how do you do it? Work at a pharmaceutical company and want to share your thought leadership? Get in touch to take part in a virtual interview to contribute to a FirstWord Expert View report. #MedicalAffairs #KOLs #Raredisease